Dr. Brianna N. Harris, MD

Dr. Harris practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Harris' NPI, 1558701144, was assigned on June 27, 2013. Dr. Harris graduated from Keck School of Medicine of USC in 2013. Dr. Harris holds California license A133452.

Dr. Harris' primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Harris' primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Harris is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Harris to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harris practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Harris' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Harris is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Harris' licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists thyroid surgery and upper respiratory infection (URI) among the conditions Dr. Harris treats.

CMS data shows 123 Medicare services from Dr. Harris across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $11,764 for them. Every service was in an office.

CMS counts 92 Medicare patients who saw Dr. Harris in 2024. The largest group is 65 to 74, with 41 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harris' median patient age at 65, with 48% women.

In 2024, Dr. Harris wrote 66 Medicare Part D claims for 33 patients. 98% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $684 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Harris for performance year 2024, reported as part of a group. Dr. Harris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of melanoma (skin cancer) excision by Dr. Harris, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Harris, published from 2011 to 2022. 2020 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Skin Neoplasms. Dr. Harris has published most often in Curr Opin Otolaryngol Head Neck Surg. Dr. Harris' most frequent co-authors are Arnaud F. Bewley, MD, Donald Gregory Farwell, MD and Aditi Arvind Bhuskute, MD.

CMS Open Payments shows 13 general payments to Dr. Harris from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Ethicon Inc. paid the most, $138.

Dr. Harris graduated from Keck School of Medicine of USC in 2013.

Dr. Harris is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.